These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9104747)
21. Efficacy and tolerability of intranasally applied dimetindene maleate solution versus placebo in the treatment of seasonal allergic rhinitis. Horak F; Unkauf M; Beckers C; Mittermaier EM Arzneimittelforschung; 2000 Dec; 50(12):1099-105. PubMed ID: 11190775 [TBL] [Abstract][Full Text] [Related]
22. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Weido AJ; Reece LM; Alam R; Cook CK; Sim TC Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780 [TBL] [Abstract][Full Text] [Related]
24. Effect of nasal anaesthesia on lacrimal function after nasal allergen challenge. Löth S; Bende M Clin Exp Allergy; 1994 Apr; 24(4):375-6. PubMed ID: 8039024 [TBL] [Abstract][Full Text] [Related]
25. [Sense of smell in allergic rhinitis]. Klimek L Pneumologie; 1998 Apr; 52(4):196-202. PubMed ID: 9610182 [TBL] [Abstract][Full Text] [Related]
26. Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis. Vaidyanathan S; Nair A; Barnes ML; Meldrum K; Lipworth BJ Clin Exp Allergy; 2009 Mar; 39(3):409-16. PubMed ID: 19187327 [TBL] [Abstract][Full Text] [Related]
27. Comparison of olfactory function in patients with seasonal and perennial allergic rhinitis. Moll B; Klimek L; Eggers G; Mann W Allergy; 1998 Mar; 53(3):297-301. PubMed ID: 9542610 [TBL] [Abstract][Full Text] [Related]
28. Unilaterality of obstruction after acute nasal allergen provocation. Relation of allergen dose, nasal reactivity and the nasal cycle. Brooks CD; Karl KJ; Francom SF Clin Exp Allergy; 1991 Sep; 21(5):583-7. PubMed ID: 1742650 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages. Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930 [TBL] [Abstract][Full Text] [Related]
30. Nasal and ocular responses after specific and nonspecific nasal challenges in seasonal allergic rhinitis. Tomljenovic D; Baudoin T; Megla ZB; Vagic D; Hellings P; Kalogjera L Ann Allergy Asthma Immunol; 2016 Mar; 116(3):199-205. PubMed ID: 26804667 [TBL] [Abstract][Full Text] [Related]
31. Effect of the nasal cycle on congestive response during bilateral nasal allergen provocation. Gotlib T; Samoliński B; Grzanka A Ann Agric Environ Med; 2014; 21(2):290-3. PubMed ID: 24959778 [TBL] [Abstract][Full Text] [Related]
32. Changes of nasal function after temperature-controlled radiofrequency tissue volume reduction for the turbinate. Rhee CS; Kim DY; Won TB; Lee HJ; Park SW; Kwon TY; Lee CH; Min YG Laryngoscope; 2001 Jan; 111(1):153-8. PubMed ID: 11192885 [TBL] [Abstract][Full Text] [Related]
33. Effect of intranasal triamcinolone acetonide on bronchial hyper-responsiveness in children with seasonal allergic rhinitis and comparison of perceptional nasal obstruction with acoustic rhinometric assessment. Oztürk F; Türktaş I; Asal K; Ileri F; Münevver Pinar N Int J Pediatr Otorhinolaryngol; 2004 Aug; 68(8):1007-15. PubMed ID: 15236886 [TBL] [Abstract][Full Text] [Related]
34. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure. Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536 [TBL] [Abstract][Full Text] [Related]
35. Important roles of tachykinins in the development of allergic nasal hyperresponsiveness in guinea-pigs. Nabe T; Tsuzuike N; Ohtani Y; Mizutani N; Watanabe S; Fujii M; Yoshimura M; Nagasawa M; Kohno S Clin Exp Allergy; 2009 Jan; 39(1):138-46. PubMed ID: 18778270 [TBL] [Abstract][Full Text] [Related]
36. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication. Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883 [TBL] [Abstract][Full Text] [Related]
37. Experimental and seasonal exposure to birch pollen in allergic rhinitis and allergic asthma with regard to the inflammatory response. Kämpe M; Janson C; Stålenheim G; Stolt I; Carlson M Clin Respir J; 2010 Jan; 4(1):37-44. PubMed ID: 20298416 [TBL] [Abstract][Full Text] [Related]
38. Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5. Linden M; Svensson C; Andersson E; Andersson M; Greiff L; Persson CG Am J Respir Crit Care Med; 2000 Nov; 162(5):1705-8. PubMed ID: 11069800 [TBL] [Abstract][Full Text] [Related]
39. Concentrations of myeloperoxidase in nasal secretions of atopic patients after nasal allergen challenge and during natural allergen exposure. Wang D; Smitz J; Derde MP; Clement P Int Arch Allergy Immunol; 1996 May; 110(1):85-90. PubMed ID: 8645984 [TBL] [Abstract][Full Text] [Related]
40. [Reproducibility and seasonal dependence of specific intranasal provocation tests in birch pollen allergy patients]. Klimek L; Reichenbach M; Mewes T; Mann W Laryngorhinootologie; 1997 Aug; 76(8):475-9. PubMed ID: 9376030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]